Some observations from in vivo studies point to a negligible effect of β-ARs on primary tumor growth, since compared to vehicle control treatment, isoproterenol stimulation of orthotopic breast cancer tumors did not change primary tumor proliferation11,23,29,30. The gene discussed is CTBP1; the disease is neoplasm.